CN106344701A - Powder medicine for treating allergic dermatitis and preparation method thereof - Google Patents
Powder medicine for treating allergic dermatitis and preparation method thereof Download PDFInfo
- Publication number
- CN106344701A CN106344701A CN201610869434.4A CN201610869434A CN106344701A CN 106344701 A CN106344701 A CN 106344701A CN 201610869434 A CN201610869434 A CN 201610869434A CN 106344701 A CN106344701 A CN 106344701A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- rhizoma
- herba
- salviae miltiorrhizae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
Abstract
The invention belongs to the field of traditional Chinese medicine preparations, and aims at providing a powder medicine for treating allergic dermatitis according to a know mechanism of traditional Chinese medicine on the allergic dermatitis. The medicine is prepared from the following components in parts by mass: 30g to 120g of rhizoma cimicifugae, 80g to 160g of salviae miltiorrhizae radix et rhizoma, 100g to 160g of radix puerariae, 30g to 120g of rhizoma chuanxiong, 40g to 120g of red peony root, 30g to 60g of fructus schisandrae chinensis, 25g to 120g of herba ephedra, 150g to 260g of herba houttuynia and 90g to 160g of flos chrysanthemi indici. The medicine provided by the invention is a traditional Chinese medicine formula capable of treating both principal and secondary aspects of diseases.
Description
Technical field
The invention belongs to field of traditional Chinese is and in particular to a kind of powder agent medicine treating anaphylaxis dermatosis and its preparation
Method, the field of powder agent medicine particularly using for patients with allergic dermatosis and preparation method thereof.
Background technology
According to data, allergic dermatitises are the dermatosiss being caused by anaphylactogen, are primarily referred to as human contact to some mistakes
Quick source and cause red swelling of the skin, itch, welt, the skin disorder such as decortication.Specific anaphylactogen can be divided into that contact allergy is former, inhale
Enter anaphylactogen, eat anaphylactogen and be injected into anaphylactogen four class.Every class anaphylactogen can cause corresponding anaphylaxiss, mainly
Performance be diversified dermatitis, eczema, urticaria.Carry out the preventing and treating of allergic dermatitises, be careful in one's diet conditioning, equilibrium battalion
Support, eat of the food that the vitamin such as water fruits and vegetables enrich more, vitamin c be natural anti-knit amine agent, daily should be from diet
Middle picked-up.
So, with regard to how to find a kind of can effectively treatment anaphylaxis dermatosis medicine, be that we are badly in need of at present solving
Problem.
Content of the invention
With the continuous development of China's Chinese medicine, on treatment anaphylaxis dermatosis, during people gradually appreciate
Cure the advantage treating anaphylaxis dermatosis, and the advantage such as good effect, instant effect, toxic and side effects are little over the course for the treatment of, for existing
There is the present situation of western medical treatment anaphylaxis dermatosis, the purpose of the present invention is to be to provide a kind of powder treating anaphylaxis dermatosis
Medicine, to solve patients with allergic dermatosis restorative problem early.This medicine is with common Chinese medicine as raw material, passes through
Select rational medicine and its mass parts ratio, can the above-mentioned anaphylaxis dermatosis of effectively treatment.
For reaching the purpose of foregoing invention, the technical solution adopted in the present invention is: provides one kind to treat allergic skin
Powder agent medicine of disease and preparation method thereof is it is characterised in that each component of described medicine and its mass parts are than as follows:
Rhizoma Cimicifugae 30~120g, Radix Salviae Miltiorrhizae 80~160g, Radix Puerariae 100~160g, Rhizoma Chuanxiong 30~120g, Radix Paeoniae Rubra 40~120g, Fructus Schisandrae Chinensis
30~60g, Herba Ephedrae 25~120g, Herba Houttuyniae 150~260g, Flos Chrysanthemi Indici 90~160g.
A kind of treat powder agent medicine of anaphylaxis dermatosis and preparation method thereof it is characterised in that described medicine each
Component and its mass parts are than as follows:
Rhizoma Cimicifugae 35~105g, Radix Salviae Miltiorrhizae 90~140g, Radix Puerariae 115~140g, Rhizoma Chuanxiong 35~105g, Radix Paeoniae Rubra 46~105g, Fructus Schisandrae Chinensis
35~50g, Herba Ephedrae 28~105g, Herba Houttuyniae 170~230g, Flos Chrysanthemi Indici 100~140g.
A kind of treat powder agent medicine of anaphylaxis dermatosis and preparation method thereof it is characterised in that described " preferred plan "
Each component of medicine and its mass parts than as follows:
Rhizoma Cimicifugae 90g, Radix Salviae Miltiorrhizae 120g, Radix Puerariae 120g, Rhizoma Chuanxiong 90g, Radix Paeoniae Rubra 90g, Fructus Schisandrae Chinensis 45g, Herba Ephedrae 90g, Herba Houttuyniae 200g, open country
Flos Chrysanthemi 120g.
A kind of treat powder agent medicine of anaphylaxis dermatosis and preparation method thereof it is characterised in that methods described include as
Lower step is prepared from:
A, above-mentioned raw materials Chinese medicine is picked impurity, dust and be dried after, be ground into powder respectively according to mass parts ratio;
B, by ground powdery medicine with, after 100 mesh screen, putting into sterilizing room sterilization processing, then mix homogeneously, so
Subpackage, sealing, obtain final product powder agent medicine afterwards.
A kind of treat powder agent medicine of anaphylaxis dermatosis and preparation method thereof it is characterised in that described instructions of taking is:
By the powder agent medicine preparing three times a day to take, the morning, noon and afternoon service once, and dosage 3.5g/time, warm boiled water, clothes
Medicine 4~6 days, symptom fades away or fully recovers.
Each raw material Chinese medicine in prescription of the present invention all has detailed note in Chinese Pharmacopoeia, Chinese dictionary and China's book on Chinese herbal medicine
Carry.It is raw material that the present invention selects most common of which Chinese medicine, gives full play to the pharmacological effect of each component:
Rhizoma Cimicifugae, nature and flavor: acrid in the mouth, sweet, cold nature, there is heat-clearing and toxic substances removing, deliver the effect of rash, ascending up spleen-Qi and Yang, treatment epidemic disease fire
Weight, women's leukorrhagia, metrorrhagia under poison, aphtha, pharyngalgia, macule, headache cold and heat, carbuncle sore tumefacting virus, sinking of QI of middle-JIAO, diarrhea due to hypofunction of the spleen, chronic dysentery
Etc. disease;
Radix Salviae Miltiorrhizae, nature and flavor: bitter in the mouth, cold nature, there is the effect of blood circulation promoting and blood stasis dispelling, menstruction regulating and pain relieving, nourishing blood to tranquillize the mind, cool blood to disappear carbuncle, treatment
Menoxenia, dysmenorrhea, amenorrhea, stasis of blood in puerperal, trusted subordinate's pain, lump in the abdomen, pyretic arthralgia swell and ache, traumatic injury, heat enter
Nutrient blood, dysphoria, vexed insomnia, ulcerative carbuncle pyogenic infections;
Radix Puerariae, nature and flavor: sweet, pungent, flat, there is expelling pathogenic factors from muscles for reducing heat;Deliver and examine;Promoting the production of body fluid to quench thirst;The effect of Shengyang Zhixie, treat diseases caused by exogenous pathogenic factor
Heating, rigidity pain on the head and nape, measles go out that smooth, epidemic febrile disease is thirsty from the beginning of, rash, diabetes, have loose bowels, dysentery, hypertension, coronary heart disease;
Rhizoma Chuanxiong, nature and flavor: pungent, warm, have that activating QI to alleviate the depression, method wind-dryness be wet, promoting blood circulation and stopping pain the effect of, treatment air-cooled headache rotation is dizzy, the side of body
Pain abdomen pain, arthralgia due to cold clonic spasm of the muscle, amenorrhea, difficult labour, postpartum stagnation block pain, ulcer sores, menoxenia, abdominal mass stomachache, chest side of body shouting pain, fall and flutter
Swell and ache, the disease such as rheumatic arthralgia;
Radix Paeoniae Rubra, nature and flavor: bitter;It is slightly cold, there is the effect of clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, treatment maculae caused by violent heat pathogen, hematemesis and epistaxiss, hemorrhoidal hamorrhage
Hematochezia, conjunctival congestion and swelling pain, carbuncle swells sore, amenorrhea, dysmenorrhea, metrorrhagia and leukorrhagia stranguria with turbid discharge, the stagnant hypochondriac pain of the stasis of blood, the accumulation of hernia abdominal mass, injury from falling down;
Fructus Schisandrae Chinensis, nature and flavor: sour, sweet, warm, there is the astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid of convergence, kidney calming, for incessant chronic diarrhea, long
Cough dyspnea due to deficiency, cardiopalmus, insomnia, dreaminess, spontaneous perspiration, night sweat, injury thirst, quench one's thirst, pass out semen, spermatorrhea;
Herba Ephedrae, nature and flavor: arduous, warm, have diaphoresis, relieving asthma, diuretic the effect of, treatment typhoid fever table is real, fever with chills is lossless, headache
The diseases such as nasal obstruction, arthralgia, cough and asthma, edema due to wind pathogen edema, dysuria, ailment said due to cold or exposure insensitive impediment, munbness, rubella itch;
Herba Houttuyniae, nature and flavor: pungent, be slightly cold, there is the effect of heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, inducing diuresis for treating stranguria syndrome, treatment lung carbuncle pyemesis, expectorant
Dyspnea of heat type is coughed, hematodiarrhoea, pyretic stranguria, carbuncle sore tumefacting virus;
Flos Chrysanthemi Indici, nature and flavor: toil, cold, there is antipyretic, diaphoretic medicine, heat and toxic materials clearing away medicine.Furuncle, carbuncle, erysipelas, eczema, skin
The diseases such as inflammation, anemopyretic cold, laryngopharynx swelling and pain, hypertension.
Medicine of the present invention is the principle based on Chinese traditional treatment anaphylaxis dermatosis, thinks from pharmacological action and mechanism of action:
With regard to anaphylaxis dermatosis, each raw material herbal medicine efficacy in medicine provided by the present invention is played altogether, above-mentioned disease is had and controls well
Therapeutic effect.
Specific embodiment
The present invention is aiming at the treatment of above-mentioned anaphylaxis dermatosis and a kind of Chinese medicine formula of proposing, using this formula system
Standby medicine effect is good, instant effect, is the Chinese prescription of a treating both the principal and secondary aspects of a disease, is particularly suitable for Clinical practice.With reference to this
Bright specific embodiment is described in further detail:
Embodiment 1:
A kind of powder agent medicine treating anaphylaxis dermatosis is it is characterised in that each component of described medicine and its mass parts ratio
As follows:
Rhizoma Cimicifugae 90g, Radix Salviae Miltiorrhizae 120g, Radix Puerariae 120g, Rhizoma Chuanxiong 90g, Radix Paeoniae Rubra 90g, Fructus Schisandrae Chinensis 45g, Herba Ephedrae 90g, Herba Houttuyniae 200g, open country
Flos Chrysanthemi 120g.
Embodiment 2:
A kind of powder agent medicine treating anaphylaxis dermatosis is it is characterised in that each component of described medicine and its mass parts ratio
As follows:
Rhizoma Cimicifugae 105g, Radix Salviae Miltiorrhizae 140g, Radix Puerariae 140g, Rhizoma Chuanxiong 105g, Radix Paeoniae Rubra 105g, Fructus Schisandrae Chinensis 50g, Herba Ephedrae 105g, Herba Houttuyniae
230g, Flos Chrysanthemi Indici 140g.
Embodiment 3:
A kind of powder agent medicine treating anaphylaxis dermatosis is it is characterised in that each component of described medicine and its mass parts ratio
As follows:
Rhizoma Cimicifugae 120g, Radix Salviae Miltiorrhizae 160g, Radix Puerariae 160g, Rhizoma Chuanxiong 120g, Radix Paeoniae Rubra 120g, Fructus Schisandrae Chinensis 60g, Herba Ephedrae 120g, Herba Houttuyniae
260g, Flos Chrysanthemi Indici 160g.
Model case
Through clinical conditions patients with allergic dermatosis totally 830, the age is 515 of more than 45 years old, and only 315 is 45
Year is following.790 of recovery from illness in 830 patients, effective 40, total effective rate reaches 100%.
Claims (3)
1. a kind of powder agent medicine treating anaphylaxis dermatosis is it is characterised in that each component of described medicine and its mass parts
Than as follows:
Rhizoma Cimicifugae 30~120g, Radix Salviae Miltiorrhizae 80~160g, Radix Puerariae 100~160g, Rhizoma Chuanxiong 30~120g, Radix Paeoniae Rubra 40~120g, Fructus Schisandrae Chinensis
30~60g, Herba Ephedrae 25~120g, Herba Houttuyniae 150~260g, Flos Chrysanthemi Indici 90~160g.
2. according to claim 1 treatment anaphylaxis dermatosis powder agent medicine it is characterised in that described medicine each
Component and its mass parts are than as follows:
Rhizoma Cimicifugae 35~105g, Radix Salviae Miltiorrhizae 90~140g, Radix Puerariae 115~140g, Rhizoma Chuanxiong 35~105g, Radix Paeoniae Rubra 46~105g, Fructus Schisandrae Chinensis
35~50g, Herba Ephedrae 28~105g, Herba Houttuyniae 170~230g, Flos Chrysanthemi Indici 100~140g.
3. the powder agent medicine of the treatment anaphylaxis dermatosis according to claim 1 to 2 is it is characterised in that described medicine
Each component and its mass parts are than as follows:
Rhizoma Cimicifugae 90g, Radix Salviae Miltiorrhizae 120g, Radix Puerariae 120g, Rhizoma Chuanxiong 90g, Radix Paeoniae Rubra 90g, Fructus Schisandrae Chinensis 45g, Herba Ephedrae 90g, Herba Houttuyniae 200g, open country
Flos Chrysanthemi 120g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610869434.4A CN106344701A (en) | 2016-10-01 | 2016-10-01 | Powder medicine for treating allergic dermatitis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610869434.4A CN106344701A (en) | 2016-10-01 | 2016-10-01 | Powder medicine for treating allergic dermatitis and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106344701A true CN106344701A (en) | 2017-01-25 |
Family
ID=57866118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610869434.4A Withdrawn CN106344701A (en) | 2016-10-01 | 2016-10-01 | Powder medicine for treating allergic dermatitis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106344701A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137526A (en) * | 2017-05-12 | 2017-09-08 | 大连大学 | A kind of Camellia nitidissima antiallergy capsule and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1343506A (en) * | 2000-09-15 | 2002-04-10 | 海国灿 | Chinese patent medicine for treating allergic dermatopathy |
-
2016
- 2016-10-01 CN CN201610869434.4A patent/CN106344701A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1343506A (en) * | 2000-09-15 | 2002-04-10 | 海国灿 | Chinese patent medicine for treating allergic dermatopathy |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107137526A (en) * | 2017-05-12 | 2017-09-08 | 大连大学 | A kind of Camellia nitidissima antiallergy capsule and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104043057A (en) | Traditional Chinese medicinal composition for treating lymph cancer | |
CN102302733B (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
CN106265999A (en) | A kind of treat cervical spondylosis, the pill medicine of lumbar spondylosis and preparation method | |
CN103550479B (en) | A kind of topical composition for the treatment of rheumatalgia | |
CN103385941A (en) | Chinese herbal medicine pain-relieving medicinal moxibustion | |
CN104971331A (en) | Orally-taken externally-applied traditional Chinese medicine composition for treating proliferation of mammary gland and preparation method | |
CN104352933A (en) | Wind-dispelling and dampness-eliminating traditional Chinese medicine containing golden buckwheat rhizomes | |
CN104274649A (en) | Medicine for treating oral ulcer | |
CN106344701A (en) | Powder medicine for treating allergic dermatitis and preparation method thereof | |
CN103623111B (en) | Traditional Chinese medicine for treating urticaria | |
CN101564522A (en) | Chinese medicament for treating intercostal nerve pain and preparation method thereof | |
CN101647981B (en) | Drug for treating blood-deficiency and wind-dry type psoriasis | |
CN104383200A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea and preparation method of traditional Chinese medicine preparation | |
CN104706780A (en) | Traditional Chinese medicine decoction for treating intercostal neuralgia | |
CN102824599B (en) | Traditional Chinese medicine tincture for treating various skin eruptions caused by diabetes | |
CN108114040A (en) | It is a kind of to be used to treat capsule medicine of allergic rhinitis and preparation method thereof | |
CN108066438A (en) | Prevent Chinese medicine composition, drug of ischemic cerebrovascular disease and its preparation method and application | |
CN107638465A (en) | A kind of Chinese medicine composition for treating arthralgia and preparation method thereof | |
CN105687533A (en) | Traditional Chinese medicine composition capable of effectively treating fundus hemorrhage and preparation method of traditional Chinese medicine composition | |
CN105327157A (en) | Traditional Chinese medicine for treating cerebrovascular blockage and preparation method thereof | |
CN105125949A (en) | Chinese drug preparation for treating syndromes after cholecystotomy | |
CN101837115B (en) | Steamed and applied traditional Chinese medicine for promoting recovery after restoration of prolapse of lumbar intervertebral disc | |
CN104096099A (en) | Traditional Chinese medicine composition for treating recurrent oral ulceration | |
CN103860704A (en) | Chinese medicinal decoction for treating intercostal neuralgia | |
CN107582973A (en) | A kind of endo-medicine and preparation method that can effectively treat ischemic cerebral disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170125 |